)
)
BeiGene Investor Relations Material
Latest events
R&D Day 2023
BeiGene
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from BeiGene Ltd
Access all reports
BeiGene Ltd. is a biotechnology company focused on the discovery, development, and commercialization of innovative oncology treatments. Established in 2010, BeiGene has expanded its operations globally, with a significant presence in markets including the United States, China, Europe, and Australia. The company's product portfolio includes a range of treatments targeting various cancers such as blood cancers, solid tumors, and myelodysplastic syndromes. BeiGene is also actively involved in collaborative projects with other pharmaceutical companies to enhance its research and development capabilities. The company is headquartered in Grand Cayman, Cayman Islands, and its shares are listed on the NASDAQ.
Key slides for BeiGene Ltd
Goldman Sachs 45th Annual Global Healthcare Conference
BeiGene Ltd
Goldman Sachs 45th Annual Global Healthcare Conference
BeiGene Ltd
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
BGNE
Country
🇺🇸 United States